We're on Fed Time<br />By Rev Shark<br />RealMoney.com Contributor<br />3/16/2010 8:49 AM EDT <br /><br />Inflation is one form of taxation that can be imposed without legislation. <br />-- Milton Friedman<br /><br />On Monday the market paused a little in its relentless uptrend, but the selling was so mild it hardly qualified as profit-taking. In the morning it looked like the selling was going to pick up, but the dip-buyers moved in after the lunch hour and helped to produce a finish near the highs of the day. The bulls remain firmly in control. <br /><br />Today the primary focus will be on the FOMC interest rate decision. No one is expecting a change in rates, but market players will be scrutinizing the accompanying policy statement for any hints about how long we can expect rates to stay at extremely low levels. The biggest obstacle this market faces will be inflationary pressures created by the flood of cheap funds. The only way the Fed has of battling that is higher interest rates, and that is never market-friendly. We don't have any obvious inflationary pressures at the moment, but the market will be keenly focused on any signs that prices are rising. <br /><br />Even though the market has this potential worry about inflation, it is very unlikely that there will be anything surprising in the FOMC policy statement today. The key language in the last report was, "With substantial resource slack continuing to restrain cost pressures and with longer-term inflation expectations stable, inflation is likely to be subdued for some time." There hasn't been any indication from Fed members that this view of inflation has changed in the last month. <br /><br />Overall the market has tended to perform very well on FOMC announcement days over the past year. The old adage about not fighting the Fed has applied -- we have generally had positive reactions to the news. The market usually drifts up into the news, and during the past year we have only had aggressive selling on the announcement once. <br /><br />According to Sentimentrader.com, there have been five times in the past 15 years when the S&P 500 closed at a new one-year high prior to a FOMC policy decision. Three times the market was within days of an intermediate-term correction. So the news has been a catalyst for a turning point when we are at highs. The market is still quite technically extended, so we need to keep that in mind in the next few days. <br /><br />The current technical condition of the market presents a challenging trading environment. There is no question we have a strong uptrend in place, but we have had so little rest recently that it is extremely difficult to be very aggressive with new buying. On the other hand, shorting has been suicide. There is just no notable or sustained weakness, and even when we do have a little selling (like yesterday morning) it doesn't last long enough to allow any shorting. <br /><br />So here we are with the uptrend showing few signs of weakness and a recent tendency to drift up in front of the FOMC news. There is little choice but to remain bullish but keep a very-short-term time frame and stay very vigilant. It hasn't paid to be bearish in front of the Fed, but quite often a strong response to the news is reversed in the next couple days. <br /><br />We have a slightly positive open shaping up. There is some economic news that may give us a jiggle but primarily we just have to wait for the FOMC announcement before we can do much. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: ATHN +6.6%, SDTH +2.9%, MCHP +2.7%, DB +1.4% (confirms 2009 net income of $6.9 bln - AP)... Select financial related names showing strength: CS +1.6%, BCS +1.6%, UBS +1.3%... Select metals/mining names trading higher: HL +1.5%, ABX +1.3%, AUY +1.2%, MT +1.0% (plans reinforcing bar joint venture in Iraq)... Other news: ICGN +74.1% (reports positive results for ICA-105665 in patients with photosensitive epilepsy), BLTI +35.1% (announces FDA 510(K) clearance of iLase personal laser for dental market), CGEN +9.5% (announces discovery platform to predict cell penetrating peptides for drug delivery), DVAX +7.5% (anticipates earlier BLA submission for HEPLISAV), DNN +4.9% (reports Phoenix high-grade uranium deposit continues to encounter 'significant results' ), PDC +4.5% (CFO bought 42,275 shares at $7.29; CEO bought 56,300 shares at $7.32), LTD +3.8% (announces $1 per share special dividend and $200 million share repurchase program), USEG +2.5% (announces initial production rate on Bakken Wells), BEXP +2.2% (announces signing of purchase and sale agreement to acquire over 10,000 Net Acres in its rough rider project area), IUSA +2.1% (SEC investigation of Infogroup is concluded), PCX +1.9% (sells metallurgical coal to Asian destinations of ~1.5 mln tons), GLW +1.8% (comments on demand for LCD TVs), AIG +1.7% (closes secondary public offering of shares in Transatlantic Holdings), NAV +1.1% (receives $178 mln contract to retrofit 1,222 MRAPs with DXM independent suspension), RDS.A +1.1% (to increase production), OFG +1.0% (priced a 7.6 mln share common stock offering at $11.40/share), MRX +1.0% (Cramer makes positive comments on MadMoney)... Analyst comments: MPEL +4.7% (upgraded to Outperform from Neutral at Credit Suisse), SONC +3.0% (upgraded to Overweight at Piper), SBUX +2.4% (upgraded to Buy at UBS). <br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: SQNM -17.5%, ADY -14.0%, EONC -12.7% (light volume), UWBK -10.5% (also downgraded to Neutral from Buy at Sterne Agee), CFSG -6.7%, GSI -6.4%, MOV -6.4%, MDVN -1.6% (also target lowered to $13 from $25 at RBC Capital), DSW -2.9%... Other news: LXRX -8.5% (prices an ~87.71 mln share common stock offering at $1.15/share), GLP -5.0% (announces public offering of 3.4 mln common units), NVAX -4.3% (filed for a $150 mln mixed shelf offering), FPO -3.8% (announces public offering of 5 mln common shares), FNSR -3.4% (files S-3ASR for mixed shelf of indeterminate amount; files for 7.2 mln share common stock offering), BXS -2.3% (revises previously reported financial results), SNIC -0.9% (light volume; files $166.5 mln mixed shelf offering in an S-3)... Analyst comments: WYN -3.0% (downgraded to Neutral at Goldman), EAT -2.8% (downgraded to Underweight at Piper), PSEC -1.9% (downgraded to Neutral at Macquarie), CAKE -1.5% (downgraded to Underweight at Piper), KMB -1.2% (added to Conviction Sell List at Goldman), SFL -1.1% (downgraded to Neutral at JPMorgan), TEVA -1.1% (removed from their Conviction Buy List at Goldman), GT -0.9% (initiated with Underweight at Morgan Stanley), UNH -0.9% (removed from their Conviction Buy List at Goldman).